Name | nan-190 hydrobromide |
Synonyms | NAN190 HYDROBROMIDE NAN 190 HYDROBROMIDE nan-190 hydrobromide NAN-190 HYDROCHLORIDE 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine hydrobromide 1-[2-METHOXYPHENYL]-4-[4-(2-PHTHALIMIDO)-BUTYL]PIPERAZINE HYDROCHLORIDE 2-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]isoindole-1,3-dione hydrobromide 2-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]isoindoline-1,3-quinone hydrobromide |
CAS | 115338-32-4 |
InChI | InChI=1/C23H27N3O3.BrH/c1-29-21-11-5-4-10-20(21)25-16-14-24(15-17-25)12-6-7-13-26-22(27)18-8-2-3-9-19(18)23(26)28;/h2-5,8-11H,6-7,12-17H2,1H3;1H |
Molecular Formula | C23H27N3O3.BrH |
Molar Mass | 474.4 |
Boling Point | 560.8°C at 760 mmHg |
Flash Point | 293°C |
Vapor Presure | 1.32E-12mmHg at 25°C |
Storage Condition | 2-8℃ |
In vivo study | NAN-190 hydrobromide (0.5 mg/kg, ip) is injected concomitantly with the effective dose of fluoxetine. NAN-190 reverses the catalepsy-improving effect of fluoxetine in 6-OHDA lesioned rats. |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R50 - Very Toxic to aquatic organisms |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S61 - Avoid release to the environment. Refer to special instructions / safety data sheets. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.108 ml | 10.54 ml | 21.08 ml |
5 mM | 0.422 ml | 2.108 ml | 4.216 ml |
10 mM | 0.211 ml | 1.054 ml | 2.108 ml |
5 mM | 0.042 ml | 0.211 ml | 0.422 ml |